Investor Profile: BanyanTree Growth Capital - Thesis, Cheque Size & How to Apply

BanyanTree Growth Capital is a Mumbai-based growth-capital investor that has spent a decade funding the companies most private equity firms overlook: mid-market businesses in manufacturing, industrial niches and smaller cities, where capital is scarce. Managed and advised by BanyanTree Finance Private Limited, it has raised around $300 million across three funds.

Investment thesis

BanyanTree Growth Capital provides growth capital for significant minority stakes, and in select cases undertakes control transactions, targeting underserved niches and geographies. Its own description of the strategy is memorable: it looks for "fallen angels" and "hidden gems", companies with strong prospects that struggle to raise capital, sometimes simply because management cannot easily communicate the case to financiers. The third fund, the BanyanTree India Growth Capital Fund, focuses on companies in Tier II and Tier III cities serving the growing lower-middle class. Sectors span food processing, financial services, pharma, healthcare, education, manufacturing and cleantech.

Fund size and cheque size

BanyanTree Growth Capital I raised about $100 million in 2008-2009, anchored by FMO and DEG, the development finance institutions of the Netherlands and Germany. BanyanTree Growth Capital II closed at $143.5 million in September 2013, again anchored by FMO and DEG, with every existing investor bar one reinvesting. Across its three funds the firm has raised approximately $300 million. The firm does not publish a standard cheque range; third-party fund data lists typical cheques of around $5 million to $10 million, and the Safex Chemicals investment from BanyanTree Growth Capital II was Rs 60 crore (about $9 million). Treat the $5 million to $10 million figure as third-party data, not a firm-published range.

Notable portfolio

BanyanTree Growth Capital had invested in 19 companies as of its Safex Chemicals deal, which funded capacity expansion, marketing and working capital for the Delhi-based agro-chemical maker with more than 6,000 dealers and plants in Bahadurgarh and Udhampur. Other portfolio names include hospitals chain GPT Healthcare, packaged food firm Nilon's, coaching services provider MT Educare, electric motor maker Rotomag Motors and Controls, renewable power firm Atria, Deepak Fasteners and Dee Development Engineers.

People and programmes

Sanjiv Singhal is managing director of BanyanTree Finance, the firm's India-based adviser, and previously worked as a banker with Citi and Standard Chartered Bank. He has described the firm's edge as combining the roles of fund manager, management consultant and investment banker for each portfolio company. The firm runs no public accelerator or fellowship programme, and no credits or perks scheme is documented in the sources reviewed. Its support is delivered deal by deal: structured and hybrid capital plus operational support.

How to apply for funding

BanyanTree Growth Capital suits founders with an established, revenue-generating mid-market company, especially in manufacturing, industrial niches, food processing, healthcare or consumer goods. The firm backs growing but capital-constrained companies, and structures hybrid capital for promoters who want to limit dilution. Founders can approach BanyanTree Finance in Mumbai: its published contact point is managing director Sanjiv Singhal at Maker Chambers V, Nariman Point, Mumbai, and the firm is reachable through its website at banyantreefinance.com. A strong application leads with revenues and margins and names the underserved niche clearly. Press reports indicated a fourth fund was being raised, so confirm which vehicle is open before pitching.